Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Unternehmen & Branche
| Name | INTUITIVE SURGICAL INC |
|---|---|
| Ticker | ISRG |
| CIK | 0001035267 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Wertpapier & Kennzahlen
| CUSIP | 46120E107 |
|---|---|
| ISIN | US46120E1073 |
| Typ | Common Stock |
| Marktkapitalisierung | 159,99 Mrd. USD |
| Beta | 1,68 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2,770,800,000 | 821,500,000 | 2.28 | 20,111,000,000 | 17,474,500,000 |
| 2025-12-31 | 10-K | 10,064,700,000 | 2,856,000,000 | 7.87 | 20,458,700,000 | 17,824,000,000 |
| 2025-09-30 | 10-Q | 2,505,100,000 | 704,400,000 | 1.95 | 19,351,800,000 | 16,929,700,000 |
| 2025-06-30 | 10-Q | 2,440,000,000 | 658,400,000 | 1.81 | 20,163,200,000 | 17,845,700,000 |
| 2025-03-31 | 10-Q | 2,253,400,000 | 698,400,000 | 1.92 | 19,220,400,000 | 17,106,400,000 |
| 2024-12-31 | 10-K | 8,352,100,000 | 2,322,600,000 | 6.42 | 18,743,200,000 | 16,433,700,000 |
| 2024-09-30 | 10-Q | 2,038,100,000 | 565,100,000 | 1.56 | 17,743,400,000 | 15,583,300,000 |
| 2024-06-30 | 10-Q | 2,009,900,000 | 526,900,000 | 1.46 | 16,649,900,000 | 14,708,300,000 |
| 2024-03-31 | 10-Q | 1,890,600,000 | 544,900,000 | 1.51 | 15,828,000,000 | 13,962,600,000 |
| 2023-12-31 | 10-K | 7,124,100,000 | 1,798,000,000 | 5.03 | 15,441,500,000 | 13,307,600,000 |
| 2023-09-30 | 10-Q | 1,743,700,000 | 415,700,000 | 1.16 | 14,712,700,000 | 12,539,000,000 |
| 2023-06-30 | 10-Q | 1,755,900,000 | 420,800,000 | 1.18 | 13,903,300,000 | 11,879,100,000 |
| 2023-03-31 | 10-Q | 1,696,200,000 | 355,300,000 | 1.00 | 13,053,200,000 | 11,217,700,000 |
| 2022-12-31 | 10-K | 6,222,200,000 | 1,322,300,000 | 3.65 | 12,974,000,000 | 11,041,900,000 |
| 2022-09-30 | 10-Q | 1,557,400,000 | 324,000,000 | 0.90 | 13,260,800,000 | 11,515,400,000 |
| 2022-06-30 | 10-Q | 1,522,100,000 | 307,800,000 | 0.85 | 13,705,200,000 | 12,023,000,000 |
| 2022-03-31 | 10-Q | 1,487,700,000 | 365,600,000 | 1.00 | 13,678,400,000 | 12,102,300,000 |
| 2021-12-31 | 10-K | 1,550,700,000 | 380,600,000 | 1.03 | 13,555,000,000 | 11,901,100,000 |
| 2021-09-30 | 10-Q | 1,403,300,000 | 380,500,000 | 1.04 | 12,934,600,000 | 11,410,900,000 |
| 2021-09-30 | 10-K | 1,403,300,000 | 380,500,000 | 1.04 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 33,613,298 | 0 | 33,613,298 | 19,037,227,455 | Neu | +100,0% | |
| BlackRock, Inc. | 30,516,153 | 0 | 30,516,153 | 17,283,128,751 | Neu | +100,0% | |
| STATE STREET CORP | 15,701,591 | 0 | 15,701,591 | 8,892,753,079 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 8,225,691 | 0 | 8,225,691 | 4,638,187,491 | Neu | +100,0% | |
| Capital World Investors | 7,856,018 | 0 | 7,856,018 | 4,449,490,526 | Neu | +100,0% | |
| FMR LLC | 6,577,517 | 0 | 6,577,517 | 3,725,242,379 | Neu | +100,0% | |
| MORGAN STANLEY | 5,741,035 | 0 | 5,741,035 | 3,251,494,145 | Neu | +100,0% | |
| NORGES BANK | 5,044,472 | 0 | 5,044,472 | 2,856,987,162 | Neu | +100,0% | |
| Blackstone Inc. | 4,891 | 0 | 4,891 | 2,770,067,000 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 4,247,380 | 0 | 4,247,380 | 2,405,547,404 | Neu | +100,0% | |
| Invesco Ltd. | 4,128,735 | 0 | 4,128,735 | 2,338,350,298 | Neu | +100,0% | |
| Fisher Asset Management, LLC | 3,784,970 | 0 | 3,784,970 | 2,143,656,405 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 3,720,529 | 0 | 3,720,529 | 2,107,158,804 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 3,526,550 | 0 | 3,526,550 | 1,997,296,858 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 3,500,681 | 0 | 3,500,681 | 1,982,645,625 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 3,445,880 | 0 | 3,445,880 | 1,951,608,597 | Neu | +100,0% | |
| JENNISON ASSOCIATES LLC | 3,209,137 | 0 | 3,209,137 | 1,817,526,972 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2,938,463 | 0 | 2,938,463 | 1,664,227,906 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,778,155 | 0 | 2,778,155 | 1,573,435,866 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 2,559,933 | 0 | 2,559,933 | 1,449,843,880 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,554,514 | 0 | 2,554,514 | 1,446,774,549 | Neu | +100,0% | |
| BAILLIE GIFFORD & CO | 2,551,357 | 0 | 2,551,357 | 1,444,986,551 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 2,510,896 | 0 | 2,510,896 | 1,422,071,190 | Neu | +100,0% | |
| Legal & General Group Plc | 2,455,521 | 0 | 2,455,521 | 1,390,708,872 | Neu | +100,0% | |
| BARCLAYS PLC | 2,242,880 | 0 | 2,242,880 | 1,270,277,518 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 2,139,849 | 0 | 2,139,849 | 1,211,925,000 | Neu | +100,0% | |
| UBS Group AG | 2,103,706 | 0 | 2,103,706 | 1,191,454,932 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 2,103,449 | 0 | 2,103,449 | 1,191,312,319 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 2,048,667 | 0 | 2,048,667 | 1,160,283,043 | Neu | +100,0% | |
| EDGEWOOD MANAGEMENT LLC | 1,811,534 | 0 | 1,811,534 | 1,025,980,396 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 1,770,453 | 0 | 1,770,453 | 1,002,713,761 | Neu | +100,0% | |
| LOOMIS SAYLES & CO L P | 1,715,487 | 0 | 1,715,487 | 971,583,229 | Neu | +100,0% | |
| Clearbridge Investments, LLC | 1,683,260 | 0 | 1,683,260 | 953,331,400 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 1,584,473 | 0 | 1,584,473 | 897,418,584 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 1,550,188 | 0 | 1,550,188 | 878,346,560 | Neu | +100,0% | |
| Assenagon Asset Management S.A. | 1,533,771 | 0 | 1,533,771 | 868,666,544 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 1,522,191 | 0 | 1,522,191 | 862,108,095 | Neu | +100,0% | |
| BROWN ADVISORY INC | 1,519,981 | 0 | 1,519,981 | 860,871,383 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 1,483,780 | 0 | 1,483,780 | 840,384,637 | Neu | +100,0% | |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,396,564 | 0 | 1,396,564 | 790,957,987 | Neu | +100,0% | |
| SANDS CAPITAL MANAGEMENT, LLC | 1,376,958 | 0 | 1,376,958 | 779,853,933 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 1,308,021 | 0 | 1,308,021 | 740,810,773 | Neu | +100,0% | |
| Winslow Capital Management, LLC | 1,269,563 | 0 | 1,269,563 | 722,499,853 | Neu | +100,0% | |
| FAYEZ SAROFIM & CO | 1,172,526 | 0 | 1,172,526 | 664,071,945 | Neu | +100,0% | |
| Capital Research Global Investors | 1,163,737 | 0 | 1,163,737 | 659,094,087 | Neu | +100,0% | |
| Pictet Asset Management Holding SA | 1,150,250 | 0 | 1,150,250 | 651,510,544 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 1,087,439 | 0 | 1,087,439 | 615,881,955 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,078,069 | 0 | 1,078,069 | 610,575,159 | Neu | +100,0% | |
| Swiss National Bank | 982,400 | 0 | 982,400 | 556,392,064 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 889,727 | 0 | 889,727 | 503,905,784 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | Ladd Amy L | Director | Open Market Sale | -119 | 463.50 | -55,156.50 | -3,5% | |
| 2026-04-28 | Ladd Amy L | Director | Open Market Sale | -500 | 473.46 | -236,730.00 | -15,0% | |
| 2026-03-10 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -105 | 493.95 | -51,864.75 | -3,3% | |
| 2026-03-09 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -645 | 485.01 | -312,831.45 | -19,8% | |
| 2026-03-06 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -648 | 490.19 | -317,643.12 | -20,1% | |
| 2026-03-05 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -648 | 495.20 | -320,889.60 | -20,3% | |
| 2026-03-04 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -2,362 | 498.68 | -1,177,883.10 | -74,6% | |
| 2026-03-03 | Widman Fredrik | Officer, VP Corporate Controller | Open Market Sale | -118 | 487.18 | -57,487.24 | -3,6% | |
| 2026-03-03 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -648 | 488.10 | -316,288.80 | -20,0% | |
| 2026-03-03 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -4,728 | 487.18 | -2,303,387.04 | -145,8% | |
| 2026-03-02 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -125 | 492.59 | -61,573.75 | -3,9% | |
| 2026-02-27 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -2,345 | 499.71 | -1,171,819.95 | -74,2% | |
| 2026-02-27 | Widman Fredrik | Officer, VP Corporate Controller | Open Market Sale | -249 | 499.71 | -124,427.79 | -7,9% | |
| 2026-02-27 | WADORS PATRICIA L | Officer, SVP Chief Human Resources Offi | Open Market Sale | -220 | 499.71 | -109,936.20 | -7,0% | |
| 2026-02-11 | Widman Fredrik | Officer, VP Corporate Controller | Open Market Sale | -133 | 494.96 | -65,829.68 | -4,2% | |
| 2026-02-11 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -421 | 494.96 | -208,378.16 | -13,2% | |
| 2026-02-10 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -105 | 494.65 | -51,938.25 | -3,3% | |
| 2026-01-29 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -126 | 520.02 | -65,522.52 | -4,1% | |
| 2026-01-27 | GUTHART GARY S | Director | Open Market Sale | -1,400 | 531.52 | -744,129.12 | -47,1% | |
| 2026-01-27 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -125 | 532.61 | -66,576.25 | -4,2% | |
| 2026-01-27 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -105 | 532.61 | -55,924.05 | -3,5% | |
| 2026-01-27 | GUTHART GARY S | Director | Open Market Sale | -24,500 | 530.10 | -12,987,403.45 | -822,0% | |
| 2026-01-27 | GUTHART GARY S | Director | Open Market Sale | -1,400 | 531.53 | -744,139.90 | -47,1% | |
| 2025-12-15 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -464 | 548.49 | -254,499.36 | -16,1% | |
| 2025-12-12 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -4,500 | 547.36 | -2,463,120.00 | -155,9% | |
| 2025-12-10 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -104 | 559.90 | -58,229.60 | -3,7% | |
| 2025-12-01 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -125 | 568.99 | -71,123.75 | -4,5% | |
| 2025-12-01 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -22,806 | 570.89 | -13,019,721.90 | -824,1% | |
| 2025-11-12 | Charlton Henry L | Officer, EVP & Chief Commercial and Mkt | Open Market Sale | -2,565 | 580.00 | -1,487,700.00 | -94,2% | |
| 2025-11-12 | BARRATT CRAIG H | Director | Open Market Sale | -750 | 580.00 | -435,000.00 | -27,5% | |
| 2025-11-12 | Charlton Henry L | Officer, EVP & Chief Commercial and Mkt | Open Market Sale | -4,731 | 580.00 | -2,743,980.00 | -173,7% | |
| 2025-11-12 | Charlton Henry L | Officer, EVP & Chief Commercial and Mkt | Open Market Sale | -2,901 | 580.00 | -1,682,580.00 | -106,5% | |
| 2025-11-12 | Charlton Henry L | Officer, EVP & Chief Commercial and Mkt | Open Market Sale | -2,898 | 580.00 | -1,680,840.00 | -106,4% | |
| 2025-11-12 | Charlton Henry L | Officer, EVP & Chief Commercial and Mkt | Open Market Sale | -636 | 580.00 | -368,880.00 | -23,3% | |
| 2025-11-10 | Miller Brian Edward | Officer, EVP & Chief Digital Officer | Open Market Sale | -2,202 | 575.00 | -1,266,150.00 | -80,1% | |
| 2025-11-10 | Miller Brian Edward | Officer, EVP & Chief Digital Officer | Open Market Sale | -1,298 | 575.00 | -746,350.00 | -47,2% | |
| 2025-11-10 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -105 | 560.00 | -58,800.00 | -3,7% | |
| 2025-11-05 | Widman Fredrik | Officer, VP Corporate Controller | Open Market Sale | -1,908 | 550.00 | -1,049,400.00 | -66,4% | |
| 2025-11-05 | Widman Fredrik | Officer, VP Corporate Controller | Open Market Sale | -159 | 550.00 | -87,450.00 | -5,5% | |
| 2025-10-29 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -125 | 543.00 | -67,875.00 | -4,3% | |
| 2025-10-28 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -1,153 | 548.43 | -632,334.49 | -40,0% | |
| 2025-10-28 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -5,030 | 548.43 | -2,758,579.76 | -174,6% | |
| 2025-10-28 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -1,379 | 548.43 | -756,278.63 | -47,9% | |
| 2025-10-24 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -1,400 | 546.18 | -764,657.60 | -48,4% | |
| 2025-10-24 | BARRATT CRAIG H | Director | Open Market Sale | -2,193 | 548.01 | -1,201,785.93 | -76,1% | |
| 2025-10-24 | Rosa David J. | Director, Officer, Chief Executive Officer (CEO) | Open Market Sale | -24,500 | 547.55 | -13,414,979.90 | -849,1% | |
| 2025-10-24 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -28,800 | 547.56 | -15,769,644.48 | -998,1% | |
| 2025-10-24 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -1,400 | 546.35 | -764,889.86 | -48,4% | |
| 2025-09-04 | Ladd Amy L | Director | Open Market Sale | -335 | 440.69 | -147,631.15 | -9,3% | |
| 2025-09-03 | Ladd Amy L | Director | Open Market Sale | -336 | 470.11 | -157,956.96 | -10,0% | |
| 2025-08-29 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -29,360 | 472.49 | -13,872,227.13 | -878,0% | |
| 2025-07-28 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -1,400 | 495.23 | -693,326.06 | -43,9% | |
| 2025-07-28 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -7,893 | 498.64 | -3,935,756.05 | -249,1% | |
| 2025-07-28 | GUTHART GARY S | Director, Officer, Executive Chair of the Board o | Open Market Sale | -1,400 | 495.24 | -693,336.70 | -43,9% | |
| 2025-07-25 | Curet Myriam | Officer, EVP & Chief Medical Officer | Open Market Sale | -4,500 | 492.48 | -2,216,160.00 | -140,3% | |
| 2025-06-06 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -216 | 563.11 | -121,631.76 | -7,7% | |
| 2025-06-05 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -215 | 560.70 | -120,550.50 | -7,6% | |
| 2025-06-04 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -215 | 552.07 | -118,695.05 | -7,5% | |
| 2025-06-03 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -215 | 550.68 | -118,396.20 | -7,5% | |
| 2025-06-02 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -215 | 549.06 | -118,047.90 | -7,5% | |
| 2025-05-16 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -20 | 563.81 | -11,276.20 | -0,7% | |
| 2025-05-15 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -22 | 560.00 | -12,320.00 | -0,8% | |
| 2025-05-14 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -22 | 563.00 | -12,386.00 | -0,8% | |
| 2025-05-13 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -22 | 561.67 | -12,356.74 | -0,8% | |
| 2025-05-12 | Brosius Mark | Officer, SVP & Chief Mfg and Supply Cha | Open Market Sale | -22 | 551.97 | -12,143.34 | -0,8% | |
| 2025-05-02 | Samath Jamie | Officer, See Remarks | Open Market Sale | -915 | 527.95 | -483,074.25 | -30,6% | |
| 2025-05-01 | NACHTSHEIM JAMI K | Director | Open Market Sale | -2,400 | 520.00 | -1,248,000.00 | -79,0% | |
| 2025-04-30 | Ladd Amy L | Director | Open Market Sale | -1,448 | 505.55 | -732,030.46 | -46,3% | |
| 2025-04-30 | Ladd Amy L | Director | Open Market Sale | -2,298 | 505.55 | -1,161,744.48 | -73,5% | |
| 2025-04-30 | Ladd Amy L | Director | Open Market Sale | -1,709 | 505.55 | -863,977.94 | -54,7% | |
| 2025-04-30 | Ladd Amy L | Director | Open Market Sale | -1,671 | 505.55 | -844,767.20 | -53,5% | |
| 2025-04-30 | Ladd Amy L | Director | Open Market Sale | -1,650 | 505.55 | -834,150.74 | -52,8% |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BENDER ROBERT & ASSOCIATES | 68,645 | 31,644,659 | 55.86 |
| GAGNON SECURITIES LLC | 31,619 | 14,576,048 | 25.73 |
| OPPENHEIMER & CO INC | 22,621 | 10,428,055 | 18.41 |